Share-based Payment Arrangement, Expense in USD of Apyx Medical Corp from 2010 to Q3 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Apyx Medical Corp quarterly/annual Share-based Payment Arrangement, Expense history and change rate from 2010 to Q3 2025.
  • Apyx Medical Corp Share-based Payment Arrangement, Expense for the quarter ending 30 Sep 2025 was $530K, a 46.8% decline year-over-year.
  • Apyx Medical Corp Share-based Payment Arrangement, Expense for the twelve months ending 30 Sep 2025 was $2.34M, a 42.8% decline year-over-year.
  • Apyx Medical Corp annual Share-based Payment Arrangement, Expense for 2024 was $4.01M, a 21.5% decline from 2023.
  • Apyx Medical Corp annual Share-based Payment Arrangement, Expense for 2023 was $5.11M, a 23.6% decline from 2022.
  • Apyx Medical Corp annual Share-based Payment Arrangement, Expense for 2022 was $6.7M, a 31.6% increase from 2021.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Change (%)
Share-based Payment Arrangement, Expense, Annual (USD)
Share-based Payment Arrangement, Expense, YoY Annual Change (%)

Apyx Medical Corp Quarterly Share-based Payment Arrangement, Expense (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2025 $2.34M $530K -$467K -46.8% 01 Jul 2025 30 Sep 2025 10-Q 06 Nov 2025
Q2 2025 $2.81M $520K -$530K -50.5% 01 Apr 2025 30 Jun 2025 10-Q 07 Aug 2025
Q1 2025 $3.34M $451K -$677K -60% 01 Jan 2025 31 Mar 2025 10-Q 08 May 2025
Q4 2024 $4.01M $838K -$76K -8.32% 01 Oct 2024 31 Dec 2024 10-K 13 Mar 2025
Q3 2024 $4.09M $997K -$354K -26.2% 01 Jul 2024 30 Sep 2024 10-Q 06 Nov 2025
Q2 2024 $4.44M $1.05M -$432K -29.2% 01 Apr 2024 30 Jun 2024 10-Q 07 Aug 2025
Q1 2024 $4.88M $1.13M -$239K -17.5% 01 Jan 2024 31 Mar 2024 10-Q 08 May 2025
Q4 2023 $5.11M $914K -$727K -44.3% 01 Oct 2023 31 Dec 2023 10-K 13 Mar 2025
Q3 2023 $5.84M $1.35M -$341K -20.2% 01 Jul 2023 30 Sep 2023 10-Q 08 Nov 2024
Q2 2023 $6.18M $1.48M -$232K -13.5% 01 Apr 2023 30 Jun 2023 10-Q 08 Aug 2024
Q1 2023 $6.41M $1.37M -$283K -17.2% 01 Jan 2023 31 Mar 2023 10-Q 09 May 2024
Q4 2022 $6.7M $1.64M +$300K +22.4% 01 Oct 2022 31 Dec 2022 10-K 21 Mar 2024
Q3 2022 $6.4M $1.69M +$508K +42.9% 01 Jul 2022 30 Sep 2022 10-Q 09 Nov 2023
Q2 2022 $5.89M $1.71M +$345K +25.2% 01 Apr 2022 30 Jun 2022 10-Q 11 Aug 2023
Q1 2022 $5.54M $1.65M +$456K +38.2% 01 Jan 2022 31 Mar 2022 10-Q 11 May 2023
Q4 2021 $5.09M $1.34M +$340K +34% 01 Oct 2021 31 Dec 2021 10-K 16 Mar 2023
Q3 2021 $4.75M $1.18M +$121K +11.4% 01 Jul 2021 30 Sep 2021 10-Q 10 Nov 2022
Q2 2021 $4.63M $1.37M +$272K +24.8% 01 Apr 2021 30 Jun 2021 10-Q 11 Aug 2022
Q1 2021 $4.36M $1.19M +$145K +13.8% 01 Jan 2021 31 Mar 2021 10-Q 12 May 2022
Q4 2020 $4.21M $1M +$3.97M 01 Oct 2020 31 Dec 2020 10-K 17 Mar 2022
Q3 2020 $240K $1.06M -$2.15M -66.9% 01 Jul 2020 30 Sep 2020 10-Q 12 Nov 2021
Q2 2020 $2.39M $1.1M -$1.05M -48.9% 01 Apr 2020 30 Jun 2020 10-Q 12 Aug 2021
Q1 2020 $3.44M $1.05M -$146K -12.2% 01 Jan 2020 31 Mar 2020 10-Q 12 May 2021
Q4 2019 $3.58M -$2.97M 01 Oct 2019 31 Dec 2019 10-K 31 Mar 2021
Q3 2019 $3.21M +$2.72M +556% 01 Jul 2019 30 Sep 2019 10-Q 09 Nov 2020
Q2 2019 $2.15M 01 Apr 2019 30 Jun 2019 10-Q 10 Aug 2020
Q1 2019 $1.2M 01 Jan 2019 31 Mar 2019 10-Q 11 May 2020
Q3 2018 $489K +$298K +156% 01 Jul 2018 30 Sep 2018 10-Q 15 Nov 2019
Q4 2017 $871K $339K +$63K +22.8% 01 Oct 2017 31 Dec 2017 10-K 31 Mar 2020
Q3 2017 $808K $191K +$18K +10.4% 01 Jul 2017 30 Sep 2017 10-Q 03 Nov 2017
Q2 2017 $790K $182K -$2K -1.09% 01 Apr 2017 30 Jun 2017 10-Q 03 Aug 2017
Q1 2017 $792K $159K -$17K -9.66% 01 Jan 2017 31 Mar 2017 10-Q 15 May 2017
Q4 2016 $809K $276K 01 Oct 2016 31 Dec 2016 10-K 14 Mar 2019
Q3 2016 $173K 01 Jul 2016 30 Sep 2016 10-Q 03 Nov 2017
Q2 2016 $184K 01 Apr 2016 30 Jun 2016 10-Q 03 Aug 2017
Q1 2016 $176K -$118M -99.9% 01 Jan 2016 31 Mar 2016 10-Q 11 May 2016
Q1 2015 $119M +$36.6M +44.6% 01 Jan 2015 31 Mar 2015 10-Q 08 May 2015
Q3 2014 $128K 01 Jul 2014 30 Sep 2014 10-Q 10 Nov 2014
Q1 2014 $82M +$82M +163900% 01 Jan 2014 31 Mar 2014 10-Q 15 May 2014
Q1 2013 $50K 01 Jan 2013 31 Mar 2013 10-Q 15 May 2013

Apyx Medical Corp Annual Share-based Payment Arrangement, Expense (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2024 $4.01M -$1.1M -21.5% 01 Jan 2024 31 Dec 2024 10-K 13 Mar 2025
2023 $5.11M -$1.58M -23.6% 01 Jan 2023 31 Dec 2023 10-K 13 Mar 2025
2022 $6.7M +$1.61M +31.6% 01 Jan 2022 31 Dec 2022 10-K 21 Mar 2024
2021 $5.09M +$878K +20.9% 01 Jan 2021 31 Dec 2021 10-K 16 Mar 2023
2020 $4.21M +$629K +17.6% 01 Jan 2020 31 Dec 2020 10-K 17 Mar 2022
2019 $3.58M +$1.36M +61% 01 Jan 2019 31 Dec 2019 10-K 31 Mar 2021
2018 $2.22M +$1.35M +155% 01 Jan 2018 31 Dec 2018 10-K 31 Mar 2020
2017 $871K +$62K +7.66% 01 Jan 2017 31 Dec 2017 10-K 31 Mar 2020
2016 $809K +$241K +42.4% 01 Jan 2016 31 Dec 2016 10-K 14 Mar 2019
2015 $568K +$180K +46.4% 01 Jan 2015 31 Dec 2015 10-K 13 Mar 2018
2014 $388K -$118K -23.3% 01 Jan 2014 31 Dec 2014 10-K 10 Mar 2017
2013 $506K +$345K +214% 01 Jan 2013 31 Dec 2013 10-K 18 Mar 2016
2012 $161K +$29K +22% 01 Jan 2012 31 Dec 2012 10-K 27 Feb 2015
2011 $132K -$31K -19% 01 Jan 2011 31 Dec 2011 10-K/A 08 May 2014
2010 $163K 01 Jan 2010 31 Dec 2010 10-K 01 Apr 2013
* An asterisk sign (*) next to the value indicates that the value is likely invalid.